Xiaoguang Chen Selected Research

sinenxan A

1/2014

A new 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) derivative overcomes paclitaxel resistance by inhibiting MAPK signaling and increasing paclitaxel accumulation in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoguang Chen Research Topics

Disease

61	Neoplasms (Cancer) 06/2022 - 07/2004
14	Infections 01/2022 - 01/2013
9	Breast Neoplasms (Breast Cancer) 11/2021 - 07/2004
7	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2009
6	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 01/2017
6	Rheumatoid Arthritis 01/2022 - 10/2011
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 02/2010
5	Acute Kidney Injury (Acute Renal Failure) 03/2022 - 05/2014
5	Inflammation (Inflammations) 02/2022 - 07/2010
4	Glioma (Gliomas) 02/2022 - 01/2019
4	Dengue (Dengue Fever) 09/2021 - 01/2014
4	Virus Diseases (Viral Diseases) 09/2021 - 10/2014
4	Ischemia 12/2019 - 04/2002
4	Stroke (Strokes) 07/2013 - 09/2003
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2007 - 04/2002
3	Albuminuria 08/2022 - 01/2017
3	Fibrosis (Cirrhosis) 02/2022 - 10/2012
3	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2022 - 01/2013
3	Arthritis (Polyarthritis) 01/2022 - 05/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2007
3	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2020 - 01/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2019 - 01/2014
3	Experimental Arthritis 01/2019 - 05/2017
3	Hypoxia (Hypoxemia) 01/2019 - 07/2012
2	Glomerulonephritis 08/2022 - 01/2020
2	Wounds and Injuries (Trauma) 02/2022 - 01/2017
2	Chronic Renal Insufficiency 01/2022 - 01/2020
2	Flavivirus Infections 09/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2021 - 06/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2020
2	Shock 08/2019 - 01/2016
2	Communicable Diseases (Infectious Diseases) 12/2018 - 03/2018
2	Triple Negative Breast Neoplasms 12/2018 - 05/2016
2	Carcinoma (Carcinomatosis) 01/2017 - 04/2010

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 08/2022 - 03/2005
20	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2007
9	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 07/2004
8	coumarinIBA 02/2022 - 02/2010
7	Biological ProductsIBA 01/2022 - 09/2004
7	MicroRNAs (MicroRNA)IBA 05/2015 - 01/2013
5	Messenger RNA (mRNA)IBA 08/2022 - 11/2015
5	Long Noncoding RNAIBA 08/2022 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2011
4	LigandsIBA 09/2022 - 04/2007
4	Phosphotransferases (Kinase)IBA 01/2020 - 12/2009
4	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 07/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 04/2007
4	NitrogenIBA 01/2017 - 01/2013
4	nicousamideIBA 01/2017 - 01/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2013 - 02/2010
3	RNA (Ribonucleic Acid)IBA 08/2022 - 11/2015
3	AntibodiesIBA 06/2022 - 07/2014
3	Antiviral Agents (Antivirals)IBA 09/2021 - 02/2018
3	Liposomes (Liposome)IBA 07/2021 - 01/2019
3	Chlorogenic AcidIBA 07/2021 - 01/2017
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 05/2016
3	EnzymesIBA 01/2021 - 01/2019
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 03/2020 - 06/2019
3	Streptozocin (Streptozotocin)FDA Link 01/2020 - 02/2010
3	CytokinesIBA 01/2020 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2016
3	AlbuminsIBA 01/2019 - 01/2013
3	Urea (Carbamide)FDA LinkGeneric 01/2017 - 01/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2022 - 01/2013
2	ProdrugsIBA 06/2022 - 01/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2022 - 01/2016
2	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2021
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 12/2019
2	GlycosidesIBA 01/2022 - 01/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 11/2007
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2021
2	AcidsIBA 01/2021 - 01/2017
2	Mannose ReceptorIBA 09/2020 - 01/2019
2	Tryptophan (L-Tryptophan)FDA Link 03/2020 - 02/2020
2	LipopolysaccharidesIBA 01/2020 - 01/2017
2	Lipocalin-2IBA 01/2020 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2014
2	InterferonsIBA 01/2020 - 07/2010
2	Bovine Serum AlbuminIBA 01/2020 - 01/2013
2	Protein Kinases (Protein Kinase)IBA 12/2019 - 12/2009
2	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2019 - 12/2009
2	MitogensIBA 12/2019 - 12/2009
2	Therapeutic UsesIBA 01/2019 - 03/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 12/2004
2	Antineoplastic Agents (Antineoplastics)IBA 12/2018 - 01/2014
2	Syl930IBA 04/2018 - 07/2014
2	MethyltransferasesIBA 02/2018 - 01/2018
2	Piwi-Interacting RNAIBA 01/2018 - 05/2015
2	InsecticidesIBA 04/2016 - 03/2012
2	manassantin AIBA 01/2016 - 01/2014
2	Interleukin-22 (IL-22)IBA 12/2015 - 10/2011
2	Caspase 3 (Caspase-3)IBA 07/2015 - 05/2013

Therapy/Procedure

13	Therapeutics 03/2022 - 09/2003
7	Oral Administration 02/2022 - 01/2014
5	Immunotherapy 06/2022 - 02/2020
4	Drug Therapy (Chemotherapy) 01/2014 - 07/2004
2	Intravenous Injections 08/2022 - 02/2022
2	Intravenous Administration 01/2020 - 12/2002
2	Aftercare (After-Treatment) 05/2017 - 07/2013